A $40-a-Year Generic of the Twice-Yearly HIV Shot Wins Tentative US Approval
The US Food and Drug Administration has given tentative approval to India’s Dr. Reddy’s for a generic lenacapavir priced at $40 per person per year in 120 countries, against about $28,000 for Gilead’s version in the United States.
2 Nov · 3 min
